SCHEMBL11344786

SCHEMBL11344786

O=C(Nc1ccc(C(=O)Nc2cc(S(=O)(=O)O)c(O)c3ccccc23)cc1)Nc1ccc(C(=O)Nc2cc(S(=O)(=O)O)c(O)c3ccccc23)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TIMP3 P35625 4/20 0.54
CD40 P25942 2/20 0.50
CD40LG P29965 2/20 0.50
FGF1 P05230 1/20 0.48
SIRT1 Q96EB6 2/20 0.46
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
F11 P03951 1/20 0.44
HPSE Q9Y251 2/20 0.43
CCR8 P51685 1/20 0.43
MCL1 Q07820 1/20 0.43
PRMT3 O60678 1/20 0.43
EP300 Q09472 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
PRMT1 Q99873 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907563 0.93 CD40 (0.50) TIMP3CD40CD40LGFGF1MEN1
SCHEMBL11355263 0.90 TIMP3 (0.54) TIMP3CD40CD40LGFGF1SIRT1
SCHEMBL11349457 0.88 KMT2A (0.58) TIMP3SIRT1MEN1USP2ALDH1A1
SCHEMBL11341705 0.86 FGF1 (0.56) TIMP3CD40CD40LGFGF1SIRT1
SCHEMBL11433031 0.86 HDAC1 (0.48) CD40CD40LGMEN1ALDH1A1RECQL
SCHEMBL11347629 0.83 HPSE (0.46) TIMP3CD40CD40LGSIRT1MEN1
SCHEMBL11351833 0.83 TIMP3 (0.55) TIMP3CD40CD40LGFGF1SIRT1
SCHEMBL10907534 0.82 CD40 (0.50) TIMP3CD40CD40LGFGF1MEN1
SCHEMBL11344807 0.82 TIMP3 (0.48) TIMP3CD40CD40LGFGF1SIRT1
SCHEMBL11347713 0.82 KCNJ6 (0.42) TIMP3SIRT1MEN1USP2RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed